JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
142.80
+1.50 (1.06%)
At close: Nov 19, 2026
DSE:JMISMDL Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 4,292 | 4,406 | 3,922 | 4,620 | 7,679 | 6,902 | |
Market Cap Growth | 23.64% | 12.34% | -15.09% | -39.84% | 11.27% | -5.68% |
Enterprise Value | 4,272 | 4,326 | 3,888 | 4,640 | 7,854 | 7,120 |
Last Close Price | 142.80 | 146.60 | 129.32 | 151.25 | 250.45 | 225.09 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | 87.32 | 118.82 | - | 68.61 |
PS Ratio | 2.48 | 2.54 | 2.08 | 2.58 | 4.38 | 2.83 |
PB Ratio | 1.70 | 1.74 | 1.50 | 1.77 | 2.96 | 2.51 |
P/TBV Ratio | 1.70 | 1.74 | 1.50 | 1.78 | 2.96 | 2.51 |
P/FCF Ratio | - | - | 39.54 | 42.20 | 360.75 | - |
P/OCF Ratio | 913.24 | 937.54 | 36.59 | 37.82 | 116.84 | 169.23 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.47 | 2.50 | 2.06 | 2.59 | 4.47 | 2.92 |
EV/EBITDA Ratio | 45.74 | 46.32 | 19.29 | 22.74 | 53.98 | 24.93 |
EV/EBIT Ratio | 141.50 | 143.29 | 28.73 | 34.81 | 110.25 | 33.53 |
EV/FCF Ratio | - | - | 39.20 | 42.39 | 368.97 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.08 |
Debt / EBITDA Ratio | 0.26 | 0.26 | 0.13 | 0.24 | 0.90 | 0.76 |
Debt / FCF Ratio | - | - | 0.26 | 0.44 | 6.24 | - |
Net Debt / Equity Ratio | -0.01 | -0.01 | -0.02 | 0.00 | 0.03 | 0.05 |
Net Debt / EBITDA Ratio | -0.21 | -0.21 | -0.28 | 0.03 | 0.56 | 0.44 |
Net Debt / FCF Ratio | 3.80 | 3.80 | -0.58 | 0.05 | 3.81 | -2.22 |
Asset Turnover | 0.58 | 0.58 | 0.63 | 0.60 | 0.55 | 0.75 |
Inventory Turnover | 2.51 | 2.51 | 2.32 | 1.94 | 1.97 | 3.24 |
Quick Ratio | 2.17 | 2.17 | 2.40 | 2.46 | 1.72 | 1.01 |
Current Ratio | 5.36 | 5.36 | 5.68 | 6.25 | 5.12 | 3.36 |
Return on Equity (ROE) | -2.34% | -2.34% | 1.72% | 1.49% | -5.62% | 3.69% |
Return on Assets (ROA) | -2.01% | -2.01% | 1.50% | 1.31% | -4.67% | 3.08% |
Return on Invested Capital (ROIC) | 1.19% | 1.19% | 1.82% | 1.50% | -5.97% | 3.67% |
Return on Capital Employed (ROCE) | 1.10% | 1.10% | 5.00% | 4.90% | 2.60% | 7.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 18, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -1.40% | -1.37% | 1.15% | 0.84% | -1.95% | 1.46% |
FCF Yield | -0.12% | -0.12% | 2.53% | 2.37% | 0.28% | -0.83% |
Dividend Yield | 0.70% | - | 0.77% | 0.65% | 0.39% | 1.57% |
Payout Ratio | - | - | 66.85% | 76.48% | - | 68.35% |
Buyback Yield / Dilution | 0.17% | -0.14% | - | - | - | - |
Total Shareholder Return | 0.87% | -0.14% | 0.77% | 0.65% | 0.39% | 1.57% |